Vascular Diseases  >>  Activase (alteplase)  >>  Phase 2
Welcome,         Profile    Billing    Logout  

5 Trials

Remove FilterRemove FilterRemove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Activase (alteplase) / Roche, Boehringer Ingelheim, Kyowa Kirin, Mitsubishi Tanabe
NCT00238537: Echoplanar Imaging Thrombolysis Evaluation Trial (EPITHET)

Completed
2
100
Europe, RoW
Alteplase t-PA
Melbourne Health, Boehringer Ingelheim
Stroke
 
04/07
CLEAR IVH, NCT00650858 / 2004-000919-26: Clinical Trial on Treatment of Intraventricular Hemorrhage

Completed
2
52
US, Canada, Europe
tissue plasminogen activator, rt-PA (thrombolytic) (Cathflo), rt-PA, Cathflo, Activase
Johns Hopkins University, FDA Office of Orphan Products Development, Genentech, Inc.
Intraventricular Hemorrhage
08/08
08/08
MISTIE, NCT00224770: Minimally Invasive Surgery and rtPA for Intracerebral Hemorrhage Evacuation

Completed
2
141
US, Canada, Europe
MIS+Cathflo Activase (drug), rtPA, Intraoperative stereotactic CT-Guided Endoscopic Surgery
Daniel Hanley, National Institute of Neurological Disorders and Stroke (NINDS), Genentech, Inc., Emissary International LLC
Intracerebral Hemorrhage
08/12
04/13
Wake-Up Stroke, NCT01183533: Safety of Intravenous Thrombolysis for Wake-up Stroke

Completed
2
40
US
Alteplase (iv t-PA), Activase®, Alteplase, tissue plasminogen activator, t-PA
The University of Texas Health Science Center, Houston, Genentech, Inc.
Ischemic Stroke
10/13
01/14
SAIL-ON, NCT01643902: Safety of Intravenous Thrombolytics in Stroke on Awakening

Completed
2
20
US
tPA, Activase, Alteplase
Johns Hopkins University, Genentech, Inc.
Stroke
12/15
12/15

Download Options